4.2. Analysis.

Comparison 4 Sensitivity analysis: serious adverse events ‐ at maximum follow‐up, Outcome 2 Serious adverse events ‐ at maximum follow‐up ‐ cumulated.

Comparison 4 Sensitivity analysis: serious adverse events ‐ at maximum follow‐up, Outcome 2 Serious adverse events ‐ at maximum follow‐up ‐ cumulated.